 HIV Infections
"HIV Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Descriptor ID |
D015658
|
| MeSH Number(s) |
C02.782.815.616.400 C02.800.801.400 C20.673.480
|
| Concept/Terms |
HIV Infections- HIV Infections
- HIV Infection
- Infection, HIV
- Infections, HIV
- HTLV-III-LAV Infections
- HTLV III LAV Infections
- HTLV-III-LAV Infection
- Infection, HTLV-III-LAV
- Infections, HTLV-III-LAV
- T-Lymphotropic Virus Type III Infections, Human
- T Lymphotropic Virus Type III Infections, Human
- HTLV-III Infections
- HTLV III Infections
- HTLV-III Infection
- Infection, HTLV-III
- Infections, HTLV-III
HIV Coinfection- HIV Coinfection
- Coinfection, HIV
- Coinfections, HIV
- HIV Coinfections
|
Below are MeSH descriptors whose meaning is more general than "HIV Infections".
Below are MeSH descriptors whose meaning is more specific than "HIV Infections".
This graph shows the total number of publications written about "HIV Infections" by people in this website by year, and whether "HIV Infections" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 13 | 0 | 13 | | 1996 | 6 | 0 | 6 | | 1997 | 2 | 2 | 4 | | 1998 | 15 | 2 | 17 | | 1999 | 18 | 4 | 22 | | 2000 | 24 | 3 | 27 | | 2001 | 19 | 2 | 21 | | 2002 | 19 | 6 | 25 | | 2003 | 15 | 11 | 26 | | 2004 | 42 | 8 | 50 | | 2005 | 31 | 6 | 37 | | 2006 | 37 | 3 | 40 | | 2007 | 43 | 8 | 51 | | 2008 | 42 | 5 | 47 | | 2009 | 48 | 7 | 55 | | 2010 | 46 | 13 | 59 | | 2011 | 74 | 11 | 85 | | 2012 | 54 | 12 | 66 | | 2013 | 68 | 13 | 81 | | 2014 | 97 | 10 | 107 | | 2015 | 75 | 10 | 85 | | 2016 | 99 | 10 | 109 | | 2017 | 94 | 13 | 107 | | 2018 | 97 | 15 | 112 | | 2019 | 94 | 12 | 106 | | 2020 | 96 | 4 | 100 | | 2021 | 135 | 7 | 142 | | 2022 | 114 | 1 | 115 | | 2023 | 92 | 1 | 93 | | 2024 | 98 | 5 | 103 | | 2025 | 22 | 4 | 26 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV Infections" by people in Profiles.
-
Kim S, Radford CE, Xu D, Zhong J, Do J, Pham DM, Travisano KA, Filsinger Interrante MV, Bruun TUJ, Rezek V, Wilder B, Palomares M, Seaman MS, Kitchen SG, Bloom JD, Kim PS. A broad antibody with enhanced HIV-1 neutralization via bispecific antibody-mediated prepositioning. Nat Commun. 2025 May 18; 16(1):4617.
-
Mainella VA, Branchford B, Nemkov T, Hosford S, Coyle RP, Johnson B, Choi YJ, Williams M, Zheng JH, Bushman L, Kiser JJ, Anderson PL, Brooks KM. Cellular pharmacology of tenofovir alafenamide and emtricitabine in neutrophils and platelets in people with and without HIV. J Antimicrob Chemother. 2025 May 02; 80(5):1224-1232.
-
Meyers K, Lane B, Zucker J, Wu Y, Carnevale C, Burnside H, Rowan S, Mayes E, Narcisse-Cempini G, Gold MA, Saldana L, Golub SA. A case study of the co-creation of the PrEP-SIC: a roadmap to support introduction of pre-exposure prophylaxis into new settings. BMC Health Serv Res. 2025 May 01; 25(1):631.
-
Hiransuthikul A, Thammajaruk N, Kerr S, Janamnuaysook R, Nonenoy S, Hongchookiat P, Trichavaroj R, Tawon Y, Boonruang J, Teeratakulpisarn N, Cressey TR, Anderson PL, Phanuphak N. No significant drug-drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 study. J Int AIDS Soc. 2025 May; 28(5):e26502.
-
Mutale W, Graybill LA, Saidi F, Phanga T, Amico KR, Freeborn K, Rosenberg NE, Hill LM, Hamoonga T, Richardson BD, Mollan KR, Chi BH. Evaluation of a combination adherence strategy to support HIV antiretroviral therapy for pregnancy and breastfeeding in Malawi: A pilot randomized clinical trial. PLoS One. 2025; 20(4):e0319735.
-
Young MR, Haddad LB, McKinnon L, Ochieng WO, Rowh M, Gill A, Ofotokun I, Mehta SD. Cytokine concentration and T cell subsets in the female genital tract in the presence of bacterial vaginosis and Trichomonas vaginalis. Front Cell Infect Microbiol. 2025; 15:1539086.
-
Peters BA, Xue X, Hanna DB, Wang Y, Wang Z, Sharma A, Floris-Moore M, Konkle-Parker D, Alcaide ML, Sheth AN, Topper EF, Weber KM, Tien PC, Merenstein D, V?squez E, Chen Y, Mimiaga MJ, Stosor V, Brown TT, Erlandson KM, Dillon SM, Elsayed NS, Usyk M, Sollecito CC, Kaplan RC, Burk RD, Qi Q. Healthy Aging and the Gut Microbiome in People With and Without HIV. J Infect Dis. 2025 Apr 15; 231(4):981-992.
-
Briganti L, Annamalai AS, Bester SM, Wei G, Andino-Moncada JR, Singh SP, Kleinpeter AB, Tripathi M, Nguyen B, Radhakrishnan R, Singh PK, Greenwood J, Schope LI, Haney R, Huang S-W, Freed EO, Engelman AN, Francis AC, Kvaratskhelia M. Structural and mechanistic bases for resistance of the M66I capsid variant to lenacapavir. mBio. 2025 May 14; 16(5):e0361324.
-
Feist WN, Luna SE, Ben-Efraim K, Filsinger Interrante MV, Amorin A, Johnston NM, Bruun TUJ, Utz A, Ghanim HY, Lesch BJ, McLaughlin TM, Dudek AM, Porteus MH. Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodies. Nat Commun. 2025 Apr 01; 16(1):3103.
-
Hiransuthikul A, Thammajaruk N, Kerr S, Janamnuaysook R, Nonenoy S, Hongchookiat P, Trichavaroj R, Tawon Y, Boonruang J, Teeratakulpisarn N, Cressey TR, Anderson PL, Phanuphak N. Exploring potential drug-drug interactions between masculinizing hormone therapy and oral pre-exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open-label pharmacokinetic study in Thailand. J Int AIDS Soc. 2025 Apr; 28(4):e26445.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|